Parnell Pharma Cash Flow - Quarterly (OTCMKTS:PARNF)

Add to My Stocks
$0.31 $0.01 (3.13%) PARNF stock closing price Mar 16, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Parnell Pharma needs to disclose. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Parnell Pharma profits one has to check the income statement and for Parnell Pharma debt one has to check the balance sheet. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Parnell Pharma stock analysis. Parnell Pharma generated $-9.01M cash from operating activities in till this quarter of 2016 Q4. The cash from operating activities for Parnell Pharma is $ 2016 Q4, which saw an increase from previous quarter.

View and download details of Parnell Pharma cash flows for latest & last 40 quarters
show more
Fiscal year is Jan - Dec2016 Q42015 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.95M1.11M
Net Increase (Decrease) in Assets Liabilities3.12M-1.7M
Cash From (used in) Discontinued Operations--
Other Adjustments Net2.05M-1.42M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.41M-1.3M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities-3.36M-4.63M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares6.72M-
Issuance (Repayment) of Debt Securities--1.09M
Increase (Decrease) in Bank & Other Borrowings9.04M10.23M
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities-0.92M-0.03M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.97M1.54M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year--
Cash & Equivalents at Year End5.29M4.26M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Parnell Pharma stock price history and Parnell Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Parnell Pharma has cash of $5.29M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Parnell Pharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Parnell Pharma lost $-9.01M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-3.77M for PARNF stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Parnell Pharma and its owners and creditors and was $14.84M till 2016 Q4. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Parnell Pharma Cash Flow

Quarterly Cash Flow Statements For Parnell Pharmaceuticals Holdings Ltd Peers

Amerisourcebergen cash flow, Acura Pharma cash flow, GlobeImmune cash flow, Sunwin Stevia cash flow